IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Fax: +39 02 96543496
Home Page: www.sandoz.it
Phar ma ceu ti cal Sales: US$ 70-75 mil lion
Prod ucts (% of Sales by Lead ing 5): 35-40%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
LANSOPRAZOLO HEX (antiulcerant)
CARVEDILOLO HEX (beta-blocker agent plain)
CEFTRIAXONE HEX (cephalosporin)
SIMVASTATINA HEX (cho les terol/triglyceride reg -
u lat ing prep a ra tion)
GENTAM/BETAM HEX (corticosteroid top i cal com -
bi na tion)
Ther a peu tic Range:
ant ac ids/antiflatulents/antiulcerants 22%
beta-block ing agents 15%
antibacterials sys temic 9%
psycholeptics 8%
psychoanaleptics 7%
Lead ing Dose Forms:
coated tab lets 30%
tab lets 25%
cap sules 24%
liq uids 7%
creams 5%
MIPHARM
Street Ad dress: Via Quaranta 12, 20141 Milano
Tel: +39 2 535481
Fax: +39 2 53548020
Email: info@mipharm.it
Home Page: www.mipharm.it
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, ex porter, packager/as sem bler, pro moter,
sales/detailer. De vel ops, man u fac tures for other
com pa nies. Prod uct ranges in clude: phar ma ceu ti -
cal prod ucts (branded, pre scrip tion, non-pre scrip -
tion), di etetic/nu tri tional prod ucts. Es tab lished
1998. 200 pharmaceutical employees in 2008.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 51-100 (2008)
Con tacts (Pharm): Chair man: Dr Giuseppe G.
Miglio; Com mer cial Op er a tions: Dr Boselli Franco,
Luca Testorelli; Man u fac ture: Luca Grisotti; Re -
search & De vel op ment: Simonetta Alvino; Gen -
eral Con tact: Giuseppe Miglio
NOVARTIS
Full Name: Novartis Farma SpA
Postal Ad dress: Casella postale 88, 21047
Saronno/VA
Street Ad dress: Largo Umberto Boccioni 1,
21040 Origgio (VA)
Tel: +39 02 96541
Fax: +39 02 96542910
Home Page: www.novartis.it
Con tacts (Pharm): Chair man: Giacomo di Nepi
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 900-950 mil lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 55-60%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
GLIVEC (antineoplastic other)
COTAREG (an gio ten sin-II an tag o nist com bi na -
tion)
SANDIMMUN NEORAL (immunosuppressive
agent)
FEMARA (cytostatic hor mone an tag o nist)
TAREG (an gio ten sin-II an tag o nist plain)
Ther a peu tic Range:
antineoplastics 20%
renin-an gio ten sin sys tem agents 17%
immunosuppressive agents 10%
cytostatic hor mone ther apy 7%
musculoskeletal drugs other 6%
Lead ing Dose Forms:
cap sules 38%
coated tab lets 22%
tab lets 14%
in fu sions 8%
am poules 4%
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Con sumer Health S.p.A.
Postal Ad dress: Casella postale 155, 21047
Saronno/VA
Street Ad dress: Largo Umberto Boccioni, 1,
21040 Origgio (VA)
Tel: +39 02 964791
Fax: +39 02 96479295
Home Page: www.novartis.it
De scrip tion: De vel oper, man u fac turer,
packager/as sem bler, im porter, dis trib u tor, pro -
moter, sales/detailer. Dis trib utes, sells/de tails for
other com pa nies. Prod uct ranges in clude: phar -
ma ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals, di -
etetic/nu tri tional prod ucts. Es tab lished 1997. 156
© 2009 IMS Health In cor po rated or its af fil i ates Page 180